These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9646009)

  • 21. Succinylcholine-vecuronium (Org NC 45) sequence for cesarean section.
    Baraka A; Noueihed R; Sinno H; Wakid N; Agoston S
    Anesth Analg; 1983 Oct; 62(10):909-13. PubMed ID: 6137170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscle relaxants in infants and children.
    Cook DR
    Anesth Analg; 1981 May; 60(5):335-43. PubMed ID: 6261612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.
    Book WJ; Abel M; Eisenkraft JB
    Drug Saf; 1994 May; 10(5):331-49. PubMed ID: 8037887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central nervous system effects of intrathecal muscle relaxants in rats.
    Szenohradszky J; Trevor AJ; Bickler P; Caldwell JE; Sharma ML; Rampil IJ; Miller RD
    Anesth Analg; 1993 Jun; 76(6):1304-9. PubMed ID: 8098920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of muscle relaxants for routine induction of anesthesia in Germany].
    Geldner G; Fuchs-Buder T; Hofmockel R; Diefenbach C; Ulm K; Blobner M
    Anaesthesist; 2003 May; 52(5):435-41. PubMed ID: 12750828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of price labeling of muscle relaxants on cost consciousness among anesthesiologists.
    Lin YC; Miller SR
    J Clin Anesth; 1998 Aug; 10(5):401-3. PubMed ID: 9702621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics.
    Swen J; Rashkovsky OM; Ket JM; Koot HW; Hermans J; Agoston S
    Anesth Analg; 1989 Dec; 69(6):752-5. PubMed ID: 2574015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of anaesthesia with propofol ('Diprivan') or thiopentone and interactions with suxamethonium, atracurium and vecuronium.
    Nightingale P; Petts NV; Healy TE; Kay B; McGuinness K
    Postgrad Med J; 1985; 61 Suppl 3():31-4. PubMed ID: 2865719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuromuscular block.
    Bowman WC
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S277-86. PubMed ID: 16402115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
    Frampton JE; McTavish D
    Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Train-of-four fade of non depolarizing muscle relaxants: an insight into the mechanism of precurarization.
    Erkola O
    Ann Fr Anesth Reanim; 1988; 7(4):299-304. PubMed ID: 3202338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review.
    Mirzakhani H; Welch CA; Eikermann M; Nozari A
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):3-16. PubMed ID: 22092267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Muscle relaxants. New substances and neuromuscular monitoring].
    Diefenbach C; Nigrovic V; Mellinghoff H; Buzello W
    Anaesthesist; 1997 Jan; 46(1):3-13. PubMed ID: 9082865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females?
    Light KP; Lovell AT; Butt H; Fauvel NJ; Holdcroft A
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):151-60. PubMed ID: 16395661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
    Ma H; Zhuang X
    Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuromuscular block: atracurium and vecuronium compared and combined.
    Black TE; Healy TE; Pugh ND; Kay B; Harper NJ; Petts HV; Sivalingham T
    Eur J Anaesthesiol; 1985 Mar; 2(1):29-37. PubMed ID: 2862032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.
    Sohn YJ; Bencini AF; Scaf AH; Kersten UW; Agoston S
    Anesth Analg; 1986 Mar; 65(3):233-9. PubMed ID: 2869721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Choice of the muscle relaxant for rapid-sequence induction.
    Sparr HJ
    Eur J Anaesthesiol Suppl; 2001; 23():71-6. PubMed ID: 11766251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular effects of non-depolarizing neuromuscular blockers in patients with aortic valve disease.
    Sethna DH; Starr NJ; Estafanous FG
    Can J Anaesth; 1987 Nov; 34(6):582-8. PubMed ID: 2890442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.